CYP cynata therapeutics limited

Ann: FDA Clears Cynata IND for Phase 2 Trial in GvHD, page-69

  1. 1,315 Posts.
    lightbulb Created with Sketch. 3973
    My bad. I didn't realise that when looking at your first post with the headline "So is the CYP safe ?", highlighting "Known sensitivity to dimethylsulfoxide (DMSO) or any other component of CYP-001" you were actually talking about the speed of enrollment based on your assumption that the median time will be 3 days or greater. Must have been hidden between the lines somewhere.

    Thank you for yet another compliment.

    Based on the many compliments received recently, you'd think we'd be looking at a SP of $1+, having some convincing (early) data from our P2 GvHD trial or a partner willing to step in FF's shoes taking up license to validate the technology. Yet here we are on 30c, waiting for P2 study locations to be revealed and sadly still single, ready to mingle.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
0.000(0.00%)
Mkt cap ! $37.28M
Open High Low Value Volume
17.0¢ 17.0¢ 16.0¢ $29.18K 176.1K

Buyers (Bids)

No. Vol. Price($)
2 66467 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 65000 1
View Market Depth
Last trade - 15.59pm 25/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.